Form 4: AdaptHealth Director Gregory Belinfanti Reports Share Acquisition and Establishes SEC Filing Authority
Insider Transaction Report
AdaptHealth Corp. Director Gregory Belinfanti reported the acquisition of 28,086 shares of common stock and the establishment of a Power of Attorney for future SEC filing compliance.
Summary
- Gregory Belinfanti, a Director of AdaptHealth Corp. (AHCO), reported the acquisition of 21,346 shares of common stock and an additional 6,740 shares of common stock on June 26, 2025, both at a price of $0.00.
- Following these transactions, Mr. Belinfanti beneficially owns a total of 73,494 shares of AdaptHealth Corp. common stock.
- An Exhibit 24 Power of Attorney, dated February 19, 2025, was filed, appointing Richard Rew and Shannone Raybon as attorneys-in-fact for Gregory Belinfanti.
- This Power of Attorney authorizes the attorneys-in-fact to prepare, execute, and submit various SEC filings, including Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144, on behalf of Mr. Belinfanti in his capacity as an officer, director, and/or 10% stockholder of AdaptHealth Corp.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even at a $0 price (likely a grant), generally indicates continued commitment and alignment with the company's performance, which is a positive signal for investors. The Power of Attorney is a standard administrative document.
Positives
- Director Gregory Belinfanti increased his beneficial ownership in AdaptHealth Corp. by acquiring 28,086 shares, indicating continued alignment with shareholder interests.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Agent | Gregory Belinfanti, a Director, granted a Power of Attorney to Richard Rew and Shannone Raybon to handle his SEC filing obligations (Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144) related to his holdings in AdaptHealth Corp. | February 19, 2025 | This streamlines compliance for the director and ensures timely and accurate regulatory filings, enhancing corporate governance efficiency for insider reporting. |
Stakeholder Impact
- Shareholders: The increase in director ownership may be viewed positively as it aligns management interests with shareholder interests.
- Regulatory Authorities: The Power of Attorney facilitates compliance with SEC reporting requirements, ensuring transparency for regulatory bodies.
Next Steps
- The Power of Attorney remains in effect, allowing the appointed attorneys-in-fact to continue filing required SEC reports on behalf of Gregory Belinfanti as long as he is subject to reporting requirements.
Key Dates
| Date | Description |
|---|---|
| February 19, 2025 | Date of execution of the Power of Attorney by Greg Belinfanti. |
| June 26, 2025 | Date of the reported acquisition transactions of common stock by Gregory Belinfanti. |
| June 30, 2025 | Date the Form 4 was signed by Richard Rew, as attorney-in-fact for Gregory Belinfanti. |
Recommendation
holdKeywords
AdaptHealth Corp, AHCO, Gregory Belinfanti, Director, Insider Trading, Form 4, SEC Filing, Share Acquisition, Beneficial Ownership, Power of Attorney, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.